-+ 0.00%
-+ 0.00%
-+ 0.00%

MONTE ROSA THERAPEUTICS, - TO INITIATE MULTIPLE PHASE 2 STUDIES OF MRT-8102 IN HIGH UNMET NEED INDICATIONS

路透·10/01/2026 11:00:02

請登錄查看新聞詳情